Booth Jeffrey David 4

What Happened

• Jeffrey David Booth, a director of Core Scientific, received an award of 18,575 restricted stock units (RSUs) on February 4, 2026. The filing reports an acquisition price of $0.00 (these are compensation RSUs, not a market purchase or sale).
• The RSUs will vest in full on February 3, 2027, provided Booth continues to serve as a non-employee director on that date. No immediate shares were delivered and no cash was paid at grant.

Key Details

• Transaction date: 2026-02-04 (reported on Form 4 filed 2026-02-06).
• Transaction type/code: Award/Grant (A) — 18,575 RSUs; price reported $0.00.
• Vesting: RSUs vest in full on 2027-02-03 contingent on continued service (footnote F1).
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Timeliness: Filing dated 2026-02-06 for a 2026-02-04 transaction — appears to be filed within the usual 2-business-day window.
• No 10b5-1 plan, tax-withholding, or immediate sale noted in this filing.

Context

• RSUs are a form of equity compensation that convert into shares (or cash equivalent) only upon vesting; they do not represent an immediate market purchase or sale. Such awards are typically compensation for service and do not by themselves signal buying pressure.
• The economic value to the director will depend on Core Scientific’s share price at vesting and any company-specific vesting or settlement terms.